Skip to content

Allphase Pharma Consulting, LLC

A Professional Service Provider for the Pharma Industry

Primary menu

CONTACT
BLOGS
LEGAL
WELCOME

Secondary menu

The News
The Viewpoint
Did you know…?
Recent Literature
QIDP Antibiotics

Tag Archives: IC

OLOROFIM in a TIGHT SPOT

Posted on September 22, 2025 by Harald — No Comments ↓

Regulatory and development status of Olorofim, a novel antifungal. Continue reading OLOROFIM in a TIGHT SPOT→

Share this:

Facebook
X
Print
Email
WhatsApp
More

Pocket
Reddit
Telegram
Bluesky
Tumblr
Nextdoor
Mastodon
Threads
Pinterest

Like this:

Like Loading...

Posted in Recent Literature, The News, The Viewpoint | Tagged Allphase Pharma Consulting, AmB, amphotericin B, antibiotic blog, antifungals, azoles, complete response letter, controlled clinical studies, CRL, drug toxicity, echinocandins, F2G Pharma, FDA, fluconazole, Harald Reinhart, hepatic toxicity, hepatotoxicity, IA, IC, invasive aspergillosis, invasive candidiasis, isavuconazole, John Rex, liposomal AMB, OASIS trial, PK, Shionogi, trial design, Voriconazole | Leave a reply

Search

Your message has been sent

Rating(required)

Warning

Δ

Chat on WhatsApp

Footer menu

CONTACT
BLOGS
LEGAL
WELCOME

Email

Copyright © 2026 Allphase Pharma Consulting, LLC. All Rights Reserved.

Theme: Catch Box by Catch Themes

" height="0" width="0" style="display:none;visibility:hidden">

%d